Aripiprazole long-acting injectable formulations for schizophrenia: aripiprazole monohydrate and aripiprazole lauroxil

Expert Review of Clinical Pharmacology
Leslie Citrome


Aripiprazole monohydrate (AM) and aripiprazole lauroxil (AL) are two different long-acting injectable formulations of aripiprazole. AM 400 mg administered once monthly demonstrated efficacy in an acute, double-blind, placebo-controlled, randomized clinical trial, as well as in a double-blind, placebo-controlled, randomized-withdrawal maintenance study, and in two non-inferiority maintenance studies. AL is a prodrug of aripiprazole and available in 441 mg, 662 mg or 882 mg strengths. AL 441 mg and 882 mg administered once monthly demonstrated efficacy in an acute, double-blind, placebo-controlled, randomized clinical trial. The pharmacokinetic profile of AL also led to approval of dosing intervals of every 6 weeks for the 882 mg dose. The overall tolerability profiles of both products are consistent with what is known about oral aripiprazole.


Nov 28, 2017·Drugs·James E Frampton
Feb 12, 2020·Drug Metabolism Reviews·Hanlan LiuChandra Prakash
Dec 30, 2015·Current Medical Research and Opinion·Pierre Chue, James Chue
Jan 20, 2016·International Journal of Clinical Practice·L Citrome


May 16, 2008·Acta Psychiatrica Scandinavica·Leslie Citrome
Jul 9, 2008·Drug Development and Industrial Pharmacy·Tushar Nahata, Tulsi Ram Saini
Jan 26, 2011·Schizophrenia Research·Maria Rosaria A MuscatelloRocco A Zoccali
Mar 3, 2011·The American Journal of Psychiatry·Jari TiihonenPasi Korhonen
May 17, 2011·Patient Preference and Adherence·François CaroliAntonio Delgado
Aug 1, 2013·Expert Review of Neurotherapeutics·Leslie Citrome
Nov 16, 2013·The Journal of Clinical Psychiatry·Taishiro KishimotoChristoph U Correll
Jun 14, 2014·The British Journal of Psychiatry : the Journal of Mental Science·W Wolfgang FleischhackerJohn M Kane
Jan 15, 2015·International Journal of Clinical Practice·L Citrome
Jan 15, 2015·Current Medical Research and Opinion·Arash RaoufiniaFrank Larsen
Jan 1, 2014·Results in Pharma Sciences·Morten RohdeRené Holm
May 26, 2015·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Pál CzoborJan Volavka
Jun 27, 2015·The Journal of Clinical Psychiatry·Herbert Y MeltzerElliot W Ehrich

Related Concepts

Antipsychotic Effect
Injection Product
Periodontal Attachment Loss
Clinical Trials, Randomized
Controlled Clinical Trials, Randomized
OPC 14597
Nonclinical Randomization

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.